These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8326617)

  • 1. Transdermal dihydrotestosterone therapy and its effects on patients with microphallus.
    Choi SK; Han SW; Kim DH; de Lignieres B
    J Urol; 1993 Aug; 150(2 Pt 2):657-60. PubMed ID: 8326617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of percutaneous administration of dihydrotestosterone in children of different genetic backgrounds with micropenis.
    Xu D; Lu L; Xi L; Cheng R; Pei Z; Bi Y; Ruan S; Luo F
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1285-1291. PubMed ID: 29176021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
    Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and effect of percutaneous administration of dihydrotestosterone in children.
    Charmandari E; Dattani MT; Perry LA; Hindmarsh PC; Brook CG
    Horm Res; 2001; 56(5-6):177-81. PubMed ID: 11910204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early determination of androgen-responsiveness is important in the management of microphallus.
    Burstein S; Grumbach MM; Kaplan SL
    Lancet; 1979 Nov; 2(8150):983-6. PubMed ID: 91775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microphallus: eventual phallic size is dependent on the timing of androgen administration.
    Husmann DA; Cain MP
    J Urol; 1994 Aug; 152(2 Pt 2):734-9. PubMed ID: 8022007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study.
    Kaya C; Bektic J; Radmayr C; Schwentner C; Bartsch G; Oswald J
    J Urol; 2008 Feb; 179(2):684-8. PubMed ID: 18082206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrinological evaluation of patients with congenital microphallus.
    Walsh PC; Wilson JD; Allen TD; Madden JD; Porter JC; Neaves WB; Griffin JE; Goodwin WE
    J Urol; 1978 Jul; 120(1):90-5. PubMed ID: 671617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.
    Kunelius P; Lukkarinen O; Hannuksela ML; Itkonen O; Tapanainen JS
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1467-72. PubMed ID: 11932266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.
    Wang C; Iranmanesh A; Berman N; McDonald V; Steiner B; Ziel F; Faulkner SM; Dudley RE; Veldhuis JD; Swerdloff RS
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2749-57. PubMed ID: 9709942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical dihydrotestosterone to treat micropenis secondary to partial androgen insensitivity syndrome (PAIS) before, during, and after puberty - a case series.
    Becker D; Wain LM; Chong YH; Gosai SJ; Henderson NK; Milburn J; Stott V; Wheeler BJ
    J Pediatr Endocrinol Metab; 2016 Feb; 29(2):173-7. PubMed ID: 26352087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.
    Ly LP; Jimenez M; Zhuang TN; Celermajer DS; Conway AJ; Handelsman DJ
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4078-88. PubMed ID: 11549629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
    Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androstanolone treatment for congenital penile curvature.
    Catuogno C; Romano G
    Eur Urol; 2001 Jan; 39 Suppl 2():28-32. PubMed ID: 11223694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summaries for Patients: Daily application of dihydrotestosterone gel does not prevent age-related growth of the prostate gland.
    Ann Intern Med; 2010 Nov; 153(10):I38. PubMed ID: 21079202
    [No Abstract]   [Full Text] [Related]  

  • 17. Topically applied testosterone and phallic growth. Its effects in male children with hypopituitarism and microphallus.
    Ben-Galim E; Hillman RE; Weldon VV
    Am J Dis Child; 1980 Mar; 134(3):296-8. PubMed ID: 7361738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal dihydrotestosterone treatment of 'andropause'.
    de Lignieres B
    Ann Med; 1993 Jun; 25(3):235-41. PubMed ID: 7687444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.
    Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Berman N; Hull L; Swerdloff RS
    J Clin Endocrinol Metab; 2004 May; 89(5):2085-98. PubMed ID: 15126525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.